top of page

GORTEC 2007-02

Patients with nonmetastatic N2b, N2c, or N3 squamous cell carcinoma of the head and neck and fit for taxotere, cisplatin, fluorouracil (TPF)

Essai Gortec 2007-02.png
Essai Gortec 2007-02 results.png

Geoffrois L, Martin L, De Raucourt D, Sun XS, Tao Y, Maingon P, et al.

Induction Chemotherapy Followed by Cetuximab Radiotherapy Is Not Superior to Concurrent Chemoradiotherapy for Head and Neck Carcinomas: Results of the GORTEC 2007-02 Phase III Randomized Trial.

J Clin Oncol. 1 nov 2018;36(31):3077‑83.

bottom of page